Introduction Glioblastoma multiforme (GBM) presents a challenging endeavor in therapeutic
management because of its highly aggressive tumor microenvironment (TME). This complex …

Glioblastoma multiforme (GBM) is an aggressive brain cancer showing poor prognosis.
Currently, treatment methods of GBM are limited with adverse outcomes and low survival …

In the context of glioblastoma treatment, the penetration of drugs is drastically limited by the
blood-brain-barrier (BBB). Emerging therapies have focused on the field of therapeutic …

Sunitinib, a versatile receptor tyrosine kinase inhibitor, shows significant clinical
effectiveness against various cancers. However, its therapeutic use is limited by non-specific …

Triple-negative breast Cancer (TNBC) is one of the deadliest types, making up about 20% of
all breast cancers. Chemotherapy is the traditional manner of progressed TNBC treatment; …

Glioblastoma multiforme (GBM) is one of the most vascular among solid tumors, and despite
the use of multimodal therapies, the survival of these patients is poor. In order to target …

Aim The aim of the present review is to shed light on the nanotechnological approaches
adopted to overcome the shortcomings associated with the delivery of venom peptides …

Impaired vascular growth resulting from reduced vascular endothelial growth factor (VEGF)
in the epithelial tissue of the glands is a primary cause of thin endometrium. Inducing …

The indole heterocycle represents one of the most important scaffolds in medicinal chemistry
and is shared among a number of drugs clinically used in different therapeutic areas. Due to …

The indole heterocycle represents one of the most important scaffolds in medicinal chemistry
and is shared among a number of drugs clinically used in different therapeutic areas. Due to …